Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Lab

This document has a comment period that ends in 56 days. (01/13/2020) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 13, 2020.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on July 24, 2019 Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810-5413 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:Start Printed Page 61075

Controlled substanceDrug codeSchedule
Tetrahydrocannabinols7370I

The company plans to synthetically bulk manufacture the controlled substance to produce analytical standards for distribution to its customers. No other activity for this drug code is authorized for this registration.

Start Signature

Dated: October 29, 2019.

William T. McDermott,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-24544 Filed 11-8-19; 8:45 am]

BILLING CODE 4410-09-P